NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) between July 25, 2024 and October 22, 2025, both dates inclusive (the “Class Period”), of the important February 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Integer common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...

New York, New York--(Newsfile Corp. - February 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phoenix Education Partners, Inc. (NYSE: PXED) resulting from allegations that Phoenix Education may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Phoenix Education securities you may be entitled to compensation without payment of any out of pocket fees or ...

Expense ratios, risk profiles, and fund size set these two gold ETFs apart for investors weighing long-term portfolio fit.iShares Gold Trust (IAU 2.57%) and SPDR Gold Shares (GLD 2.66%) both offer simple access to gold prices, but IAU charges a lower expense ratio, while GLD manages more assets under management (AUM) and has seen less severe historical drawdowns.Both IAU and GLD are physically backed gold exchange-traded funds (ETFs) designed to mirror the price movement of gold bullion, appealing to invest ...

Each week we run a DCF (Discounted Cash Flow) model on a company from our watchlist. This week’s pick: The Walt Disney Company (DIS).ProfileDisney is a diversified global entertainment conglomerate spanning media networks, streaming, content production, theme parks, consumer products, and cruise/hospitality assets. Its revenue ecosystem combines subscription streaming (Disney+, Hulu, ESPN+), theatrical releases, linear networks, and experiential park attendance, enabling deep cross-brand monetization and IP ...

As part of our ongoing series at The Acquirer’s Multiple, each week we highlight a stock from our Stock Screeners that may be a deeply undervalued opportunity hiding in plain sight.This week’s spotlight is Westlake Chemical Partners LP (WLKP) — the MLP affiliate of Westlake Corp., specializing in ethylene production and long-term feedstock supply under highly contracted arrangements.Business OverviewWLKP operates a streamlined and capacity-secured ethylene production business with Westlake Corp. as its prim ...

Major U.S. stock indexes closed lower on Thursday, with the Dow Jones Industrial Average sliding 1.2% to 48,908.72, the S&P 500 falling 1.2% to 6,798.40, and the Nasdaq dropping 1.59% to 22,540.58.These are the top stocks that gained the attention of retail traders and investors through the day.Amazon’s stock closed down 4.42% at $222.69, after reaching an intraday high of $226.31 and a low of $220.38. The stock’s 52-week range is between $258.60 and $161.43. In the after-hours trading, the stock crashed ne ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased F5, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - The Class Period for the F5 securities is from October 28, 2024, to October 27, 2025, inclusive [1]. - Investors who purchased F5 securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 17, 2026 [2]. Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3]. - The firm has been ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]. Group 3: Case Allegations - The lawsuit alleges that F5's management misrepresented the company's revenue outlook and growth potential while downplaying risks associated with seasonality and macroeconomic factors [4]. - It is claimed that F5's optimistic statements about its security capabilities were misleading, as the company was facing a significant security incident that jeopardized its clients' security and future prospects [4]. - The lawsuit asserts that when the true information became public, investors suffered damages [4].

Posting strong Q4 results yesterday evening, Alphabet (GOOGL)  stock still dipped half a percentage point in Thursday’s trading session as investors pondered its massive spending plans.Some profit-taking may have also contributed to GOOGL falling as much as 8% before paring back early morning losses.The debate of whether it’s too soon to buy Alphabet shares following its strong Q4 report is intensified, considering GOOGL has rallied more than +70% in the last year with market-leading returns of over +200% i ...

The exercise equipment company's all-important holiday quarter was a bust.Shares of Peloton Interactive (PTON 27.24%) plunged on Thursday after the exercise bike and treadmill maker's quarterly results fell short of investors' expectations.By the close of trading, Peloton's stock price was down more than 25%. Sluggish salesPeloton's revenue fell by $17 million to $657 million in its fiscal 2026 second quarter, which ended on Dec. 31. That was $8 million below management's forecast.Membership price increases ...

There's another fight brewing around GLP-1 drugs -- this time on the delivery side.The headline-grabbing battle in the GLP-1 space pits pharmaceutical giants Eli Lilly (LLY 7.82%) and Novo Nordisk (NVO 8.18%) against each other. That makes sense, since they both make GLP-1 drugs.However, another battle is brewing that could be even larger, as Amazon (AMZN 4.36%) starts selling GLP-1 pills, competing with sellers like Hims & Hers (HIMS 3.67%), WW International (WW 6.42%), and GoodRx (GDRX +4.98%).The big dev ...